<DOC>
	<DOCNO>NCT00667706</DOCNO>
	<brief_summary>The sleeve gastrectomy utilized first-stage bariatric procedure reduce surgical risk high-risk patient induction weight loss gain popularity standalone procedure treatment morbid obesity . It appear technically easy and/or faster laparoscopic procedure Roux-en-Y gastric bypass . It bring good weight loss result , study even comparable RYGB Biliopancreatic Diversion Duodenal Switch . The mechanism action assume purely restrictive , neurohumoral interaction may exist . Almost data exist influence sleeve gastrectomy medical general quality life resolution comorbidities . The rate comorbidities resolution 12 24 month sleeve gastrectomy report range seem higher purely restrictive procedure . Our goal compare surgical weight loss outcomes two procedure , influence resolution common comorbidities quality life change . 150 eligible candidate randomize two group , one undergo Laparoscopic Sleeve Gastrectomy , Laparoscopic Roux-en-Y Gastric Bypass do . Detailed evaluation preoperative questionnaire use obtain demographic medical data , quality life assess . General metabolic nutritional work do , reassess different interval 5 year , order compare short long term result two procedure .</brief_summary>
	<brief_title>Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Sleeve Gastrectomy</brief_title>
	<detailed_description />
	<mesh_term>Obesity , Morbid</mesh_term>
	<criteria>Adult patient morbid obesity Pregnancy , Previous bariatric operation , IBD , Previous bowel stomach surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>